Evidence map›Paper›PMID 39328711›Full record

ReviewCureus2024

Epidemiology, Virology, and Mutation Landscape of Monkeypox Virus From Past to Present.

Suganandhini Mani, Alagammai Ganesan, Thirumalai Arunagiri, Vamsi Ravi Kumaran, Kanaka Parvathi Kannaiah, Chitra Vellapandian, Hemanth Kumar Chanduluru

Abstract readReview
In one paragraph

Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Suganandhini ManiPharmacy, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, IND.
Alagammai GanesanPharmacy, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, IND.
Thirumalai ArunagiriPharmacy, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, IND.
Vamsi Ravi KumaranPharmacy, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, IND.
Kanaka Parvathi KannaiahPharmacy, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, IND.
Chitra VellapandianPharmacy, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, IND.
Hemanth Kumar ChanduluruPharmacy, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monkeypox (Mpox) has emerged as a significant threat to the global population. Initially identified in a rural area of Africa in 1970, after the eradication of smallpox, it spread rapidly across various African nations. The ongoing evolution of the monkeypox virus (MPXV), which causes Mpox, and its potential for cross-species transmission led to a global outbreak in 2022. Despite the control measures during the outbreak, Mpox cases continue in several African nations, posing a persistent public health threat. Global surveillance is crucial to eradicating MPXV from human populations and preventing its resurgence. Factors contributing to MPXV's increased transmissibility and immune evasion include its mutation rate, adaptability, and genetic evolution. Therefore, understanding the epidemiology and virology of Mpox is essential for developing effective prevention and control strategies. This study explores the history of human Mpox, the complexity of MPXV, how it replicates, and drug-resistant mutations. It will also stress how important it is to study how the circadian clock affects virus replication in infectious diseases in order to effectively fight this new public health threat. Understanding these aspects is crucial for developing effective strategies against Mpox as well as addressing the challenges posed by genetic mutations and resistance. The compiled information in this review underscores the critical need for continued research and monitoring to tackle the evolving dynamics of Mpox and its broader impact on global health.

Indexed as

epidemiology of mpoxmonkeypoxmonkeypox virusmpoxmpxvorthopoxviruspoxviridae infection

Identifiers

PMID39328711
PMCPMC11424752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.